Published: June 11, 2010

Salient Surgical Technologies Sues Bovie Medical for Patent Infringement

Share This Story

Salient Surgical Technologies, Inc., a privately held medical technology company that develops and markets advanced energy devices for use in surgical procedures, announced that Tuesday they filed a lawsuit in the U.S. District Court for the District of Delaware against Bovie® Medical (NYSE Amex: BVX) for patent infringement. The complaint charges that Bovie's manufacture, use, and sale of the SEER (Saline Enhanced Electrosurgical Resection) device infringes U.S. Patent No. 7,364,579, titled "Fluid-assisted Electrosurgical Device" (the '579 Patent). Salient has licensed the '579 Patent from Medtronic Corporation, which is also a plaintiff in the case.

About Salient Surgical Technologies
Salient Surgical Technologies, Inc. (www.salientsurgical.com) is a medical technology company that develops and markets advanced energy devices for use in surgical procedures. Salient's proprietary TRANSCOLLATION® technology allows surgeons to rapidly treat tissue at the surgical site by transforming specific types of collagen-based structures to improve patient outcomes. Salient's products are currently used in orthopedic reconstruction and trauma, reconstruction, spine surgery and surgical oncology. To date, TRANSCOLLATION technology has been used in over 400,000 surgical procedures.